FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Early clinical · first deals Testing several immuno-oncology candidates in trials at home and abroad while generating new ones.

  • Presented two new platform-derived candidates as posters at AACR. Source
  • Received approval for an amended phase 1/2 trial plan. Source

Roles often seen at this stageClinical & PV · Research & development · BD & licensing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

GI Innovation

A biotech developing bispecific fusion proteins for immuno-oncology, testing several candidates in clinical trials in Korea and abroad.

GI-101A

Phase 2

Immuno-oncology candidate in a randomized phase 2 combination study with a checkpoint inhibitor.

GI-102

Phase 1

Immuno-oncology candidate whose subcutaneous phase 1 dose-escalation results were presented at a congress.

GI-SMART

Technology platform

Protein-design platform for generating new candidates.

Completion reported

Presented two new platform-derived candidates as posters at the AACR annual meeting.

Completion reported

Received approval for an amended phase 1/2 trial plan.

Official role guide

GI Innovation careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 3

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 지아이이노베이션, GI-SMART 플랫폼 기반 신규 파이프라인 지속 도출… AACR 2026서 2건 포스터 발표 ↗한국경제 · Published 2026-04-09 · Sources checked 2026-11-15 · Original unavailable
  2. 지아이이노베이션, 임상시험 계획 변경 승인 획득 ↗네이트 뉴스 · Published 2026-02-04 · Sources checked 2026-11-15 · Original unavailable
  3. 지아이이노베이션, 'GI-102' 피하주사 임상 성과 'ESMO IO 2026'서 발표 ↗더바이오 · Published Date unconfirmed · Sources checked 2026-11-15 · Original unavailable